Breaking News Instant updates and real-time market news.

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06

Axovant Phase 3 Alzheimer's study misses co-primary endpoints

Axovant Sciences announced that the Phase 3 Mindset clinical trial of its investigational drug intepirdine in patients with mild to moderate Alzheimer's disease who were receiving background donepezil therapy did not meet its co-primary efficacy endpoints. At 24 weeks, patients treated with 35 mg of intepirdine did not experience improvement in cognition or in measures of activities of daily living as measured by the Alzheimer's Disease Assessment Scale-Cognitive Subscale and by the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale, respectively, compared to patients treated with placebo. In the study, intepirdine was generally well tolerated, the company added. After 24 weeks of treatment, change from baseline in cognition was non-significantly improved in the intepirdine arm versus the placebo arm. In addition, there was essentially no difference between the intepirdine and placebo arms in change from baseline in activities of daily living. Of the endpoints analyzed to date, the only endpoint in which any significant improvement was seen in the intepirdine arm versus the placebo arm was in the first key secondary endpoint, the Clinician Interview-Based Impression of Change plus caregiver interview, or CIBIC-plus. Axovant said, "The Company will work with investigators to conclude the MINDSET open-label extension study. " David Hung, CEO of Axovant, added, "While we are deeply disappointed by these trial results, we also are saddened for the millions of patients and families impacted by Alzheimer's disease. However, we believe that the fight against Alzheimer's and other important areas of unmet need in neurology is too important to be derailed by this setback.... We remain committed to advancing our pipeline." Axovant shares remain halted. They closed yesterday down 6c to $22.59.

AXON Axovant Sciences
$24.25

-0.74 (-2.96%)

09/14/17
JEFF
09/14/17
NO CHANGE
Target $40
JEFF
Buy
Axovant looks 'very intriguing' at $20 per share, says Jefferies
Jefferies analyst Michael Yee believes the recent selloff in shares of Axovant Sciences presents a "unique" buying opportunity. At around $20 per share, the stock looks "very intriguing," Yee tells investors in a research note. The analyst sees "significant" potential upside, to $40-$100 per share, if the Phase III Alzheimer's data this month is positive. Yee's downside case is $3-$10 per share on negative data. Investors "should and will" buy the large selloff on negative data because CEO David Hung is likely to pivot the company, bring in more assets, and create value "from there pretty quickly," the analyst contends. Yee has a Buy rating on Axovant with a $40 price target. He thinks the Phase III Alzheimer's data has a 50%-60% chance of being positive.
09/08/17
EVER
09/08/17
NO CHANGE
Target $30
EVER
Outperform
Axovant Sciences assumed with an Outperform at Evercore ISI
Evercore ISI analyst Josh Schimmer assumed coverage on Axovant Sciences with an Outperform and a $30 price target.
07/12/17
OPCO
07/12/17
NO CHANGE
OPCO
Outperform
Axovant Sciences upcoming results may drive valuation upside, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Axovant Sciences faces two substantial binary events including the Phase 3 MINDSET study results at the end of September and the Phase 2 HEADWAY study results in Q4. The combination of these two events could drive up to 100% valuation upside, he contends. Further, the analyst believes the company is positioned to deliver the first new symptomatic Alzheimer's Disease drug approved by the FDA in over a decade. Olson reiterates an Outperform rating on the shares.
07/10/17
JEFF
07/10/17
INITIATION
Target $40
JEFF
Buy
Axovant Sciences initiated with a Buy at Jefferies
Jefferies analyst Michael Yee initiated Axovant Sciences with a Buy and a $40 price target.

TODAY'S FREE FLY STORIES

LOGI

Logitech

$37.15

0.44 (1.20%)

05:26
10/24/17
10/24
05:26
10/24/17
05:26
Earnings
Logitech reports Q2 EPS 40c, consensus 35c »

Reports Q2 revenue $634M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ALXN

Alexion

$135.20

-3.82 (-2.75%)

05:25
10/24/17
10/24
05:25
10/24/17
05:25
Hot Stocks
Alexion announces FDA approval of Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 06

    Nov

FFKT

Farmers Capital Bank

$44.00

0.2 (0.46%)

05:23
10/24/17
10/24
05:23
10/24/17
05:23
Hot Stocks
Farmers Capital Bank raises quarterly dividend by 2.5c to 12.5c per share »

Farmers Capital Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBTX

Veritex

$26.94

-0.17 (-0.63%)

05:21
10/24/17
10/24
05:21
10/24/17
05:21
Hot Stocks
Veritex announces branch office sales, terms not disclosed »

Veritex Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:19
10/24/17
10/24
05:19
10/24/17
05:19
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VECO

Veeco

$21.75

0.5 (2.35%)

05:18
10/24/17
10/24
05:18
10/24/17
05:18
Downgrade
Veeco rating change  »

Veeco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:16
10/24/17
10/24
05:16
10/24/17
05:16
Initiation
PQ Group initiated  »

PQ Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRTO

Criteo

$46.14

0.13 (0.28%)

, AAPL

Apple

$156.17

-0.08 (-0.05%)

05:15
10/24/17
10/24
05:15
10/24/17
05:15
Downgrade
Criteo, Apple rating change  »

Criteo downgraded to…

CRTO

Criteo

$46.14

0.13 (0.28%)

AAPL

Apple

$156.17

-0.08 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:10
10/24/17
10/24
05:10
10/24/17
05:10
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$26.58

0.25 (0.95%)

05:08
10/24/17
10/24
05:08
10/24/17
05:08
Initiation
Tronox initiated  »

Tronox initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:06
10/24/17
10/24
05:06
10/24/17
05:06
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$24.35

-2.82 (-10.38%)

05:04
10/24/17
10/24
05:04
10/24/17
05:04
Recommendations
Arconic analyst commentary  »

Arconic selloff yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:01
10/24/17
10/24
05:01
10/24/17
05:01
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

$20.08

0.01 (0.05%)

04:59
10/24/17
10/24
04:59
10/24/17
04:59
Recommendations
ON Semiconductor analyst commentary  »

ON Semiconductor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TECH

Bio-Techne

$123.88

-0.37 (-0.30%)

04:58
10/24/17
10/24
04:58
10/24/17
04:58
Recommendations
Bio-Techne analyst commentary  »

Bio-Techne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 30

    Nov

ABT

Abbott

$56.08

-0.24 (-0.43%)

, DXCM

Dexcom

$44.77

-0.01 (-0.02%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Analysts discuss…

ABT

Abbott

$56.08

-0.24 (-0.43%)

DXCM

Dexcom

$44.77

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 01

    Nov

  • 06

    Nov

DDAIF

Daimler AG

$80.60

0.03 (0.04%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PAY

Verifone

$19.85

-0.21 (-1.05%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Verifone management to meet with Craig-Hallum »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 14

    Dec

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

, CARO

Carolina Financial

$36.80

0.63 (1.74%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

CARO

Carolina Financial

$36.80

0.63 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

AQXP

Aquinox

$12.47

-0.27 (-2.12%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 07

    Dec

MRK

Merck

$63.40

-0.48 (-0.75%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.40

-0.48 (-0.75%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

PFE

Pfizer

$36.40

-0.02 (-0.05%)

AGN

Allergan

$187.77

-0.51 (-0.27%)

ONCE

Spark Therapeutics

$83.69

1.82 (2.22%)

PODD

Insulet

$61.02

-0.56 (-0.91%)

ACHN

Achillion

$4.01

-0.14 (-3.37%)

SNY

Sanofi

$49.62

0.11 (0.22%)

ABEO

Abeona Therapeutics

$18.60

-0.4 (-2.11%)

JNJ

Johnson & Johnson

$143.62

1.22 (0.86%)

AZN

AstraZeneca

$34.39

-0.23 (-0.66%)

SHPG

Shire

$144.78

-0.47 (-0.32%)

GSK

GlaxoSmithKline

$40.62

-0.22 (-0.54%)

BMY

Bristol-Myers

$63.75

-0.67 (-1.04%)

SCMP

Sucampo

$10.10

-0.2 (-1.94%)

PCRX

Pacira

$32.95

-0.55 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

, C

Citi

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
eSHOW to hold a conference »

Money 20/20 is being held…

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

C

Citi

CSCO

Cisco

$34.35

0.1 (0.29%)

BLK

BlackRock

$474.39

-2.23 (-0.47%)

BX

Blackstone

$34.72

0.26 (0.75%)

B

Barnes Group

$70.96

-0.93 (-1.29%)

BCS

Barclays

$10.27

-0.04 (-0.39%)

AMZN

Amazon.com

$966.30

-16.61 (-1.69%)

AKAM

Akamai

$51.46

-0.41 (-0.79%)

CS

Credit Suisse

$16.04

-0.06 (-0.37%)

DFS

Discover

$66.84

0.27 (0.41%)

IBM

IBM

$159.55

-2.52 (-1.55%)

INTC

Intel

$40.83

0.4 (0.99%)

SSNLF

Samsung

PAY

Verifone

$19.85

-0.21 (-1.05%)

MA

MasterCard

$145.56

0.18 (0.12%)

SPLK

Splunk

$64.23

0.14 (0.22%)

V

Visa

$107.53

-0.02 (-0.02%)

WFC

Wells Fargo

$54.91

-0.01 (-0.02%)

GOOG

Alphabet

$968.45

-19.75 (-2.00%)

MSFT

Microsoft

$78.83

0.02 (0.03%)

WMT

Wal-Mart

$88.65

1.21 (1.38%)

GS

Goldman Sachs

$242.13

-2.6 (-1.06%)

FB

Facebook

$171.27

-3.71 (-2.12%)

RY

Royal Bank of Canada

$80.19

-0.07 (-0.09%)

T

AT&T

$35.25

-0.29 (-0.82%)

JEF

Bought by LUK

ADBE

Adobe

$172.16

-3.48 (-1.98%)

BAC

Bank of America

$27.16

-0.01 (-0.04%)

DB

Deutsche Bank

$16.63

-0.35 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 17

    Nov

  • 21

    Nov

  • 29

    Nov

  • 29

    Nov

  • 11

    Dec

  • 14

    Dec

  • 15

    Jan

  • 20

    Feb

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 04

    May

  • 14

    Jul

  • 12

    Oct

ASOMY

ASOS

$73.88

-0.4 (-0.54%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
Breaking General news story  »

Week of 10/21 Redbook to…

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

October PMI Composite…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.